BFM
CLPT icon

Boothbay Fund Management’s ClearPoint Neuro CLPT Stock Holding History

Boothbay Fund Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,027
Closed -$93.1K – 1884
2023
Q1 		$93.1K Sell
11,027
-47
-0.4% -$412 ﹤0.01% 1955
2022
Q4 		$93.8K Buy
+11,074
New +$105K ﹤0.01% 1804

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Boothbay Fund Management's CLPT Position: Q2 2023 in Review

Boothbay Fund Management sold out of ClearPoint Neuro (CLPT) in Q2 2023, closing a stake of 11,027 shares — an estimated $93.1K sold.

Boothbay Fund Management first reported a position in CLPT in Q4 2022 and held it in 2 quarters. The position peaked at $93.8K in Q4 2022. 60 funds tracked by Wall St. Rank hold CLPT as of Q2 2023.

  • Boothbay Fund Management reported no remaining ClearPoint Neuro position as of Q2 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 11,027 ClearPoint Neuro shares in Q2 2023, an estimated $93.1K.
  • Boothbay Fund Management first reported a position in ClearPoint Neuro in Q4 2022 and held it in 2 quarters.
  • Boothbay Fund Management's ClearPoint Neuro position peaked at $93.8K in Q4 2022.
  • 60 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.